Suzanne Shusterman

Suzanne Shusterman, MD, is an Attending Physician at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Assistant Professor of Pediatrics at Harvard Medical School. She specializes in neuroblastoma and pediatric oncology, with extensive clinical trial experience in treating relapsed/refractory solid tumors.

• University of Pennsylvania (Undergraduate, 1989)
• University of Massachusetts (Medical School, 1993)
• Boston Children's Hospital (Pediatrics Internship, 1994)
• Boston Combined Residency Program (Pediatrics Residency, 1996)
• Children's Hospital of Philadelphia (Pediatric Hematology-Oncology Fellowship, 2000)

Dr. Shusterman's research focuses on neuroblastoma treatment optimization, including molecular profiling for precision trials, hypofractionated radiotherapy for palliative care, and novel drug combinations with agents like LY3295668 erbumine and lorlatinib. Her work addresses critical challenges in high-risk neuroblastoma recurrence and parental decision-making for palliative treatment goals.

Recent publications highlight her involvement in MIBG therapy, genomic subtyping of pediatric tumors, and anti-angiogenesis strategies. She serves on the faculty at Harvard Medical School and collaborates with the NANT Consortium and Children's Oncology Group.

• Phone: 888-733-4662
• Fax: 617-632-5710
• Email: suzanne_shusterman@dfci.harvard.edu
• NPI: 1275579237